Liminal BioSciences Inc.
Liminal BioSciences Inc. (LMNL) Stock Overview
Explore Liminal BioSciences Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
27.6M
P/E Ratio
-1.25
EPS (TTM)
$-6.83
ROE
-0.73%
LMNL Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Liminal BioSciences Inc. (LMNL) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $1.51.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.25 and a market capitalization of 27.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.